John P Grady

8PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial.

|Feb 13, 2026
Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation.

Benjamin Koh, Subotheni Thavaneswaran, Frank Lin

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Oct 01, 2025
High-throughput 3D engineered paediatric tumour models for precision medicine.

MoonSun Jung, Valentina Poltavets, Joanna N Skhinas

|Jun 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations.

Subotheni Thavaneswaran, Maya Kansara, Frank Lin

|Dec 01, 2022
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an <i>NRG1</i> Fusion.

Subotheni Thavaneswaran, Wei Yen Chan, Ray Asghari

Pageof 2

Frequent Collaborators

4 joint publications

Subotheni Thavaneswaran

3 joint publications

David Thomas

3 joint publications

Mandy L Ballinger

2 joint publications

R John Simes